Early HCV-RNA clearance in HIV/HCV-coinfected patients treated with pegylated interferon alfa-2a plus ribavirin

被引：0
|
作者：
Camino, N
Nuñez, M
Romero, M
Barreiro, P
Ocampo, A
Miralles, C
Martín-Carbonero, L
Fernández, A
García-Samaniego, J
Soriano, V
机构：
[1] Carlos III HOsp, Madrid, Spain
[2] Xeral Cies Hosp, Vigo, Spain
[3] Arquitecto Marcide Hosp, Ferrol, Spain
来源：
HEPATOLOGY | 2004年 / 40卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：402A / 403A
页数：2
相关论文
共 50 条
  • [21] Blood transaminase elevation with pegylated interferon alfa 2b plus ribavirin in an HIV/HCV coinfected haemophilic patient
    Guitton, E.
    Barange, K.
    Bagheri, H.
    Claeyssens, S.
    Bonnet, E.
    Massip, P.
    Montastruc, J. L.
    Vinel, J. P.
    [J]. INFECTION, 2006, 34 (03) : 183 - 185
  • [22] The safety and efficacy of taribavirin plus pegylated interferon alfa-2a versus ribavirin plus pegylated interferon alfa-2a in therapy-naive patients infected with hcv: Phase 3 results
    Marcellin, P.
    Lurie, Y.
    Rodrigues-Torres, M.
    Chasen, R.
    Xu, Y.
    Murphy, B.
    [J]. JOURNAL OF HEPATOLOGY, 2007, 46 : S7 - S7
  • [23] Differences in liver fibrosis and response to pegylated interferon plus ribavirin in HIV/HCV-coinfected patients with normal vs elevated liver enzymes
    Maida, I.
    Martin-Carbonero, L.
    Sotgiu, G.
    Vispo, E.
    Barreiro, P.
    Gonzalez-Lahoz, J.
    Soriano, V.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2010, 17 (12) : 866 - 871
  • [24] Peginterferon alfa-2a Plus Ribavirin for HIV-HCV Genotype 1 Coinfected Patients: A Randomized International Trial
    Rodriguez-Torres, Maribel
    Slim, Jihad
    Bhatti, Laveeza
    Sterling, Richard
    Sulkowski, Mark
    Hassanein, Tarek
    Serrao, Rosario
    Sola, Ricard
    Bertasso, Anne
    Passe, Sharon
    Stancic, Saray
    [J]. HIV CLINICAL TRIALS, 2012, 13 (03): : 142 - 152
  • [25] Short Communication Impact of Hepatitis C Viral Clearance on CD4+ T-Lymphocyte Course in HIV/HCV-Coinfected Patients Treated with Pegylated Interferon Plus Ribavirin
    Milazzo, Laura
    Foschi, Antonella
    Mazzali, Cristina
    Viola, Anita
    Ridolfo, Annalisa
    Galli, Massimo
    Antinori, Spinello
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2012, 28 (09) : 789 - 793
  • [26] Efficacy of safety of therapy with interferon alfa-2a plus ribavirin in HIV/HCV coinfected patients. Preliminary results of an open prospective study
    Galeras, JA
    Tural, C
    Force, L
    Montoliu, S
    de Castro, JAR
    Coll, S
    Fuster, D
    Barrufet, P
    Dominguez, MD
    Planas, R
    [J]. JOURNAL OF HEPATOLOGY, 2003, 38 : 142 - 142
  • [27] IL23 PROMOTES INTERFERON RESPONSIVENESS IN HIV/HCV COINFECTED PATIENTS TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN
    Odigie, Madeline
    Zhang, Xiaozhen
    Masur, Henry
    Polis, Michael A.
    Kottilil, Shyam
    Osinusi, Anu
    [J]. HEPATOLOGY, 2011, 54 : 488A - 488A
  • [28] Baseline serum hepatitis C virus (HCV) RNA level and response at week 4 are the best predictors of relapse after treatment with pegylated interferon plus ribavirin in HIV/HCV-coinfected patients
    Nunez, Marina
    Marino, Angel
    Miralles, Celia
    Berdun, Miguel A.
    Sola, Julio
    Hernandez-Burruezo, Juan Jose
    Galindo, Maria Jose
    Barreiro, Pablo
    Martin-Carbonero, Luz
    Soriano, Vincent
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 45 (04) : 439 - 444
  • [29] Baseline serum hepatitis c virus (HCV) RNA level and response at week 4 are the best predictors of relapse after treatment with pegylated interferon plus ribavirin in HIV/HCV-Coinfected patients
    Nunez
    Schweighardt
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 47 (04) : 528 - 528
  • [30] Incidence, predictors and management strategies of anemia in HIV/HCV coinfected patients treated with PEGylated interferon and ribavirin
    Angeli, Elena
    Bruno, Raffaele
    Cariti, Giuseppe
    Carosi, Giampiero
    Pontali, Emanuele
    Cattelan, Anna Maria
    Gulminetti, Roberto
    Maida, Ivana
    Nasta, Paola
    Verucchi, Gabriella
    Caputo, Antonietta
    Iannacone, Claudio
    Puoti, Massimo
    [J]. HEPATOLOGY, 2012, 56 : 1021A - 1021A
12345